Floatz logo

Indocyanine Green

Acute Cholangitis

Ohio State UniversitySmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Acute Cholangitis cohort.

Asset / SponsorPhaseRating
Gentamycin
National University of Malaysia
Phase 2CCC
Allocetra-Ots
Enlivex Therapeutics Ltd.
Phase 2NR

Same molecule, other indications

Indocyanine Green is also rated in:

cervical cancerDormant
BB
Indicative ·
70 / 100
View asset →
endometrial carcinomaDormant
BB
Indicative ·
70 / 100
View asset →
vulva cancerDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →